شرکت گروه دارویی برکت
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian
No Result
View All Result
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian
No Result
View All Result
شرکت گروه دارویی برکت
No Result
View All Result
  • Home Page
  • News
  • Media
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian
Home Stock News

The organization of the stock exchange and securities was examined

“Barakat” received a license to increase its capital by 27%

bpharmed by bpharmed
20 فروردین 1401
in Stock News
0 0
A A
0
0
SHARES
113
VIEWS

According to the Young Reporters Club Economic Group Stock Exchange Reporter, based on an advertisement published on the Kadal website (Exchange Publishers Information System) by Barakat Pharmaceutical Group Company on September 1, 1400, Barakat shares were allowed to increase their capital by 27% from shareholders’ current claims and brought cash. In the amount of 154 billion Tomans, it was issued as follows:

Pursuant to the Securities Market Law of the Islamic Republic of Iran (approved in December 2005), the demand for capital increase and the issuance of new shares of Barakat Public Joint Stock Company) in the Stock Exchange and Securities Organization were examined.

Previous Post

Take a look at the portfolio of Barakat Pharmaceutical Group in January

Next Post

Holding the first memorial for the martyrs of pharmacy in the presence of the Minister of Health

bpharmed

bpharmed

Next Post

Holding the first memorial for the martyrs of pharmacy in the presence of the Minister of Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

The specific vaccine “Amicron” is produced by Iranian scientists

The result of a scientific study on the effectiveness of the Barakat vaccine

Holding the first memorial for the martyrs of pharmacy in the presence of the Minister of Health

“Barakat” received a license to increase its capital by 27%

Take a look at the portfolio of Barakat Pharmaceutical Group in January

Shareholders read “Barakat” (January 7) / Price drop for the third day in a row

شرکت گروه دارویی برکت

Barkat Pharmaceutical Group is one of the largest pharmaceutical holding Companies with more than 20 subsidiaries. The company’s name was was changed to “Tadbir innovation pharmaceutical company” in 2010.

Latest News

The scientific article of phase one and two of Bovine Bovine vaccine was published in BMJ open journal

The scientific article of phase one and two of Bovine Bovine vaccine was published in BMJ open journal

24 فروردین 1401

The specific vaccine “Amicron” is produced by Iranian scientists

20 فروردین 1401

Contact Us

Address : No. 11, 5th Alley, Bucharest Ave, Argentina Sq, Tehran, Iran

Phone :  +98 21 88480161

Email : info@bpharmed.com

Email Affairs Stock : stock@bpharmed.com

Follow Us

Copyright © 2020-2022 by www.bpharmed.com All Rights Reserved
powered by ravian

  • صفحه اصلی
  • Subsidiaries
  • About Us
  • Contact Us
No Result
View All Result
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Persian

Copyright © 2020-2022 by www.bpharmed.com All Rights Reserved
powered by ravian

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist